Shares of FibroGen slid by a staggering 47.68% in 30 days from $40.41 to $21.14 at 20:14 EST on Friday, after three sequential sessions in a row of gains. NASDAQ Composite is jumping 1.44% to $14,016.81, following last session’s downward trend,
FibroGen’s last close was $21.12, 170.62% under its 52-week high of $57.21.
The company’s growth estimates for the current quarter and the next is 2.2% and 51.6%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $21.14 at 20:14 EST, way below its 52-week high of $57.21 and above its 52-week low of $20.68.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.
More news about FibroGen.